Medicare Enrolled
Dr. Sleman Khoury, MD
Endocrinology · Southgate, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Khoury from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khoury?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Khoury
Dr. Sleman Khoury is an endocrinology specialist in Southgate, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Khoury performed 2,019 Medicare services across 1,296 unique beneficiaries.
Between the years covered by Open Payments, Dr. Khoury received a total of $84,177 from 70 pharmaceutical and/or device companies across 1382 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Khoury is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 21% volume in MI
$84,177 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,019
Medicare services
Top 21% in MI for endocrinology
1,296
Unique beneficiaries
$78
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~101 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
780 | $90 | $139 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
441 | $42 | $60 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
204 | $65 | $100 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
150 | $108 | $200 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
104 | $27 | $120 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
81 | $139 | $185 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
69 | $86 | $140 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
59 | $59 | $100 |
| New patient office visit, complex (60-74 min) | 50 | $148 | $240 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
41 | $144 | $300 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
15 | $70 | $100 |
| Ultrasound-guided fine needle aspiration biopsy, first lesion A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session. |
13 | $113 | $180 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
12 | $48 | $230 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$84,177
Total received (2018-2024)
Avg $12,025/year across 7 years
Top 9% in MI for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
70
Companies
1,382
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$61,981 (73.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,196 (26.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,746
2023
$3,640
2022
$3,713
2021
$3,538
2020
$5,034
2019
$37,198
2018
$27,309
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$673
CeQur Corporation
$320
Tandem Diabetes Care, Inc.
$316
Novo Nordisk Inc
$303
Amgen Inc.
$252
Dexcom, Inc.
$230
Abbott Laboratories
$212
Corcept Therapeutics
$169
Antares Pharma, Inc.
$168
Novartis Pharmaceuticals Corporation
$138
SANOFI-AVENTIS U.S. LLC
$137
Ascensia Diabetes Care Us Inc.
$91
Xeris Pharmaceuticals, Inc.
$88
Astellas Pharma US Inc
$86
ABBVIE INC.
$79
Bayer Healthcare Pharmaceuticals Inc.
$79
Insulet Corporation
$71
PFIZER INC.
$64
Amneal Pharmaceuticals LLC
$51
Esperion Therapeutics, Inc.
$49
Boehringer Ingelheim Pharmaceuticals, Inc.
$45
RECORDATI_RARE_DISEASES_INC.
$36
Nevro Corp.
$32
Neurocrine Biosciences, Inc.
$26
Chiesi USA, Inc.
$16
BETA BIONICS, INC.
$16
Top 3 companies account for 35.0% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$23,186
Janssen Pharmaceuticals, Inc
$22,191
SANOFI-AVENTIS U.S. LLC
$18,054
Lilly USA, LLC
$3,123
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,183
Corcept Therapeutics
$1,728
Amgen Inc.
$1,692
AstraZeneca Pharmaceuticals LP
$1,489
Tandem Diabetes Care, Inc.
$658
Dexcom, Inc.
$589
Endo Pharmaceuticals Inc.
$536
Merck Sharp & Dohme Corporation
$472
Xeris Pharmaceuticals, Inc.
$460
Abbott Laboratories
$456
Antares Pharma, Inc.
$451
Becton, Dickinson and Company
$405
Amneal Pharmaceuticals LLC
$390
Insulet Corporation
$372
Amarin Pharma Inc.
$364
CeQur Corporation
$342
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$321
AbbVie, Inc.
$313
Bayer HealthCare Pharmaceuticals Inc.
$277
ABBVIE INC.
$253
Regeneron Healthcare Solutions, Inc.
$246
Novartis Pharmaceuticals Corporation
$240
AbbVie Inc.
$220
Bayer Healthcare Pharmaceuticals Inc.
$217
Amryt Pharma Holdings Ltd
$181
Kowa Pharmaceuticals America, Inc.
$175
Ascendis Pharma Inc
$169
MannKind Corporation
$168
RECORDATI_RARE_DISEASES_INC.
$165
Esperion Therapeutics, Inc.
$153
Ultragenyx Pharmaceutical Inc.
$144
Shire North American Group Inc
$141
DEXCOM, INC.
$134
Alexion Pharmaceuticals, Inc.
$122
Supernus Pharmaceuticals, Inc.
$99
Radius Health, Inc.
$93
PFIZER INC.
$91
Ascensia Diabetes Care Us Inc.
$91
Astellas Pharma US Inc
$86
Embecta Corp.
$73
Nevro Corp.
$64
Mannkind Corporation
$64
Ipsen Biopharmaceuticals, Inc
$62
Janssen Scientific Affairs, LLC
$59
Averitas Pharma Inc.
$55
Horizon Therapeutics plc
$54
EUSA Pharma (US) LLC
$52
Zealand Pharma US, Inc.
$51
Nestle HealthCare Nutrition Inc.
$38
EISAI INC.
$35
Alvogen Inc
$30
GRT US Holding, Inc.
$28
Currax Pharmaceuticals LLC
$27
Neurocrine Biosciences, Inc.
$26
Ascendis Pharma, Inc.
$24
Strongbridge US INC.
$24
Lexicon Pharmaceuticals, Inc.
$21
Aytu BioScience, Inc
$20
Gilead Sciences, Inc.
$20
Rhythm Pharmaceuticals, Inc.
$20
Medtronic, Inc.
$17
IBSA Pharma Inc.
$16
Chiesi USA, Inc.
$16
BETA BIONICS, INC.
$16
ARALEZ PHARMACEUTICALS US INC.
$14
Medtronic MiniMed, Inc.
$13
Top 3 companies account for 75.4% of all-time payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · BD NANO · BD Nano · BD Nano 2nd Gen Pen Needle · Belviq · CONTRAVE · CREON · CYCLOSET · CeQur Simplicity · Corlanor · Creon · Cryvista · DEXCOM G6 TRANSMITTER · DIABETES - DISEASE · DISEASE STATE · Dexcom G6 Transmitter · EVENITY · EVERSENSE 365 SENSOR KIT (RETAIL) · EVERSENSE E3 SENSOR KIT - RETAIL · FARXIGA · FORTEO · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · Fycompa · GVOKE PFS · HUMULIN · HUMULIN R 500 · HUMULIN U · INVOKANA · ISTURISA · InPen · Inpefa · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · LINZESS · LOKELMA · Livalo · MACRILEN · MOUNJARO · MYCAPSSA · Macrilen · Minimed 630G · NASCOBAL · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NOCDURNA · Natesto · NovoLog · OTREXUP · Omnia · Omnipod · Otrexup · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Prolia · QUTENZA · Qutenza · RECORLEV · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SKYTROFA · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · STEGLATRO · STEGLUJAN · STRENSIQ · SYNTHROID · Saxenda · Senza · Strensiq · Sylvant · TEPEZZA · TERIPARATIDE · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UNITHROID · V-GO DISPOSABLE INSULIN DELIVERY · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XYOSTED · Xultophy 100/3.6 · ZEGALOGUE · ZENPEP · ZEPBOUND · ZONTIVITY · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (74%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 9% for endocrinology in MI.
Geographic Context
Endocrinologists within 10 mi
73
Per 100K population
4.1
County median income
$59,521
Nearest hospital
WYANDOTTE HOSPITAL AND MEDICAL CENTER
2.5 mi
2.5 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Khoury is a clinical cardiology specialist, with above-average Medicare volume (top 21% in MI), with speaking/promotional industry engagement in the top 9% of MI peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Khoury experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Khoury performed 780 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Khoury receive payments from pharmaceutical companies?
Yes. Dr. Khoury received a total of $84,177 from 70 companies across 1,382 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khoury's costs compare to other endocrinologists in Southgate?
Dr. Khoury's average Medicare payment per service is $78. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khoury) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Southgate
Browse endocrinologists in Southgate ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in MI
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in MI
Which MI endocrinologists receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
SANOFI-AVENTIS U.S. LLC Payments to Doctors
See all physicians who received payments from SANOFI-AVENTIS U.S. LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology